Product Details for NDA 017029
HEPARIN SODIUM (HEPARIN SODIUM)
1,000 UNITS/ML
Marketing Status: Prescription
10,000 UNITS/ML
Marketing Status: Prescription
10,000 UNITS/ML
Marketing Status: Prescription
20,000 UNITS/ML
Marketing Status: Prescription
40 UNITS/ML
Marketing Status: Prescription
50 UNITS/ML
Marketing Status: Prescription
100 UNITS/ML
Marketing Status: Prescription
50 UNITS/ML
Marketing Status: Prescription
100 UNITS/ML
Marketing Status: Prescription
1,000 UNITS/ML
Marketing Status: Prescription
5,000 UNITS/ML
Marketing Status: Prescription
10,000 UNITS/ML
Marketing Status: Prescription
20,000 UNITS/ML
Marketing Status: Prescription
1,000 UNITS/ML
Marketing Status: Prescription
10,000 UNITS/ML
Marketing Status: Prescription
5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
1,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
10,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
10,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 020
Approval Date: Mar 31, 2011
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 020
Approval Date: Mar 31, 2011
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
20,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
40 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 021
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 40 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 021
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
50 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 022
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 022
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
100 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 023
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 023
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
50 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 024
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 024
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
100 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 025
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM IN PLASTIC CONTAINER (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 100 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N017029
Product Number: 025
Approval Date: Aug 24, 2017
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
1,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 013
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM IN PLASTIC CONTAINER (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 013
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
5,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 014
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM IN PLASTIC CONTAINER (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 014
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
10,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 015
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM IN PLASTIC CONTAINER (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 015
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
20,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 016
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM PRESERVATIVE FREE (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 016
Approval Date: Dec 5, 1985
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
1,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 010
Approval Date: Apr 28, 1986
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM PRESERVATIVE FREE (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 010
Approval Date: Apr 28, 1986
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
10,000 UNITS/ML
Marketing Status: Prescription
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 019
Approval Date: Nov 22, 2010
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
HEPARIN SODIUM (HEPARIN SODIUM)
Proprietary Name: HEPARIN SODIUM PRESERVATIVE FREE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017029
Product Number: 019
Approval Date: Nov 22, 2010
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017029
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017029
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information